Alumni Excellence Awards: Terp Research Award Winner Bryan Dickinson ’05
Synthetic biology is no longer the stuff of science fiction. Technology is allowing researchers to engineer molecules that prevent disease, better diagnose illness and create new therapies.
Helping to advance the field is Bryan Dickinson, a chemistry professor at the University of Chicago since 2014. The lab he established that year, the Dickinson Group, is an interdisciplinary research team that seeks to create “functional molecules” that could lead to biological discoveries and technologies.
Dickinson is using engineered molecules to rewire cell processes. Cells are critical to the immune system, as they maintain health and prevent disease.
